Axim Biotechnologies, Inc.

0.0069

-0.0002-2.42%

Volume:37.69K

Turnover:275.28

Market Cap:2.28M

PE:-0.33

High:0.0077

Open:0.0060

Low:0.0060

Close:0.0070

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Axim Biotechnologies Inc. Reports Significant Increase in Sales and Net Income for Q1 2025, Boosts EPS

Reuters

·

20 May

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AXIM"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXIM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXIM\",,,,,undefined,":{"symbol":"AXIM","market":"US","secType":"STK","nameCN":"Axim Biotechnologies, Inc.","latestPrice":0.00685,"timestamp":1748635200000,"preClose":0.00702,"halted":0,"volume":37690,"delay":15,"floatShares":258000000,"shares":333000000,"eps":-0.02057,"marketStatus":"Closed","change":-0.00017,"latestTime":"05-30 16:00:00 EDT Delay","open":0.006,"high":0.0077,"low":0.006,"amount":275.2819,"amplitude":0.242165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02057,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748851200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.00702,"volumeRatio":0.275957},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXIM\",,,,,undefined,":{"symbol":"AXIM","floatShares":258000000,"roa":"-36.27%","roe":"-10019.09%","lyrEps":-0.035397,"volumeRatio":0.275957,"shares":333000000,"dividePrice":0,"high":0.0077,"amplitude":0.242165,"preClose":0.00702,"low":0.006,"week52Low":0.0013,"pbRate":"-0.24","psRate":"24.55","week52High":0.019,"institutionHeld":0,"latestPrice":0.00685,"eps":-0.02057,"divideRate":0,"volume":37690,"delay":15,"ttmEps":-0.02057,"open":0.006,"prevYearClose":0.0019,"prevWeekClose":0.0065,"prevMonthClose":0.0067,"prevQuarterClose":0.0038,"fiveDayClose":0.0068,"twentyDayClose":0.0076,"sixtyDayClose":0.003},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AXIM\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXIM\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536382658","title":"Axim Biotechnologies Inc. Reports Significant Increase in Sales and Net Income for Q1 2025, Boosts EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2536382658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536382658?lang=en_us&edition=fundamental","pubTime":"2025-05-20 05:14","pubTimestamp":1747689289,"startTime":"0","endTime":"0","summary":"Axim Biotechnologies Inc. released its latest results, reporting a notable shift in its financial performance. The company, known for developing diagnostic healthcare solutions, experienced a significant change in its revenue streams following the acquisition of Sapphire Biotech, Inc. Actual revenue figures showed a substantial increase compared to the previous period, largely attributed to the integration of Sapphire's operations. In terms of profitability, Axim reported a variation in net income, reflecting the impact of the recent business expansion. The company's earnings per share also experienced a notable change, indicative of its evolving market position post-acquisition. The acquisition of Sapphire Biotech, Inc. in March 2020 marked a strategic shift in Axim's business operations, with Sapphire now operating as a wholly owned subsidiary. This acquisition has been pivotal in consolidating Axim's financial reporting, signaling a significant development in its operational scope a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL2NHlz6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXIM"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXIM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-16","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-20","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1700456400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-21","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1692590400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXIM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXIM\",market:\"US\",delay:false,,,undefined,":{}}}